Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA approves Endologix's PowerFit extensions to improve stent placement

This article was originally published in Clinica

Executive Summary

Endologix's PowerFit aortic extensions have been approved by the US FDA, via a premarket approval (PMA) supplement. The extensions are designed to allow the precise placement of devices such as stents during the repair of abdominal aortic aneurysms. The PowerFit devices, which are visible under fluoroscopy, will be available in a range of sizes, and can be used with Endologix's existing products, including Powerlink bifurcated stents and the IntuiTrak endovascular system. The Irvine, California firm plans a limited launch of the products during the third quarter, followed by full US release in the fourth quarter.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT095293

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel